Robledo-Cadena, D.X.; Gallardo-Pérez, J.C.; Dávila-Borja, V.; Pacheco-Velázquez, S.C.; Belmont-DÃaz, J.A.; Ralph, S.J.; Blanco-Carpintero, B.A.; Moreno-Sánchez, R.; RodrÃguez-EnrÃquez, S.
Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells. Pharmaceuticals 2020, 13, 463.
https://doi.org/10.3390/ph13120463
AMA Style
Robledo-Cadena DX, Gallardo-Pérez JC, Dávila-Borja V, Pacheco-Velázquez SC, Belmont-DÃaz JA, Ralph SJ, Blanco-Carpintero BA, Moreno-Sánchez R, RodrÃguez-EnrÃquez S.
Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells. Pharmaceuticals. 2020; 13(12):463.
https://doi.org/10.3390/ph13120463
Chicago/Turabian Style
Robledo-Cadena, Diana Xochiquetzal, Juan Carlos Gallardo-Pérez, VÃctor Dávila-Borja, Silvia Cecilia Pacheco-Velázquez, Javier Alejandro Belmont-DÃaz, Stephen John Ralph, Betsy Alejandra Blanco-Carpintero, Rafael Moreno-Sánchez, and Sara RodrÃguez-EnrÃquez.
2020. "Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells" Pharmaceuticals 13, no. 12: 463.
https://doi.org/10.3390/ph13120463
APA Style
Robledo-Cadena, D. X., Gallardo-Pérez, J. C., Dávila-Borja, V., Pacheco-Velázquez, S. C., Belmont-DÃaz, J. A., Ralph, S. J., Blanco-Carpintero, B. A., Moreno-Sánchez, R., & RodrÃguez-EnrÃquez, S.
(2020). Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells. Pharmaceuticals, 13(12), 463.
https://doi.org/10.3390/ph13120463